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Background: The introduction of the Solomon technique for the treatment of twin-twin transfusion
syndrome (TTTS) increased placental exposure to laser energy. This study aims to identify the impact of
power and energy used in laser treatment on placental tissue and pregnancy outcome.
Methods: Pictures of all dye-injected placentas since the start of the Solomon trial were analyzed.
Placental damage was scored using a grading system including visual scar depth and affected proportion
of the vascular equator. Parameters analyzed included laser power and total energy, gestational age (GA)
at laser, GA at birth, laser-to-delivery interval and preterm prelabor rupture of membranes (PPROM).
Results: We included 122 cases in the analysis. More placental damage occurred more often in the
Solomon group (42%) compared to the selective group (15%) (p < 0.001). In multivariate analysis, more
placental damage was associated with higher laser energy (regression coefficient B 0.002) but not with
higher power setting (regression coefficient B 0.442). More damage was associated with earlier GA at
birth (regression coefficient B 0.167), higher incidence of PPROM <32 weeks (regression coefficient B
0.003) and a shorter laser-to-delivery interval (regression coefficient B 0.168).
Conclusions: Placental damage is positively associated with more laser energy but negatively associated
with higher power setting. More placental damage was associated with a lower GA at birth, shorter laser-
to-delivery interval and higher PPROM rate. Whether these results should lead to a change in surgical
technique requires more research, both further ex-vivo experiments on human placentas and clinical
studies.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Monochorionic (MC) twin pregnancies are high-risk pregnan-
cies, often (10%) complicated by twin-twin transfusion syndrome
(TTTS). Untreated, this condition is associated with approximately
90% perinatal mortality and severe morbidity [1e3]. Survival rates
increase significantly after treatment with fetoscopic laser therapy




In 2008, the Solomon technique was introduced as an adapta-
tion of the selective fetoscopic laser coagulation technique for the
treatment of TTTS complicated MC pregnancies [5]. The rationale
behind the Solomon technique is to eliminate even the smallest
anastomoses by coagulating a line between the visible anastomo-
ses, thereby avoiding residual anastomoses leading to recurrence of
TTTS or occurrence of post-laser twin anemia polycythemia
sequence (TAPS). We concluded that the Solomon technique
significantly reduces the incidences of recurrent TTTS and post-
laser TAPS [5].
A possible drawback of the Solomon technique is a larger sur-
face area of the placenta being exposed to laser energy, compared
to the selective laser coagulation technique (Fig. 1). Animal studies
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loss of the entire underlying cotyledon [6]. Little research has been
conducted on the impact of laser energy and laser power setting
(wattage) on the human placental tissue. Emery et al. described the
effect of Solomon laser treatment after pathological analysis on a
human placenta. They concluded that solomonization leads to de-
vitalization of the chorionic plate with shallow devitalization of the
underlying villi [7].
A worldwide expert survey showed significant variation in laser
power settings between centers [8]. Furthermore, it showed that
the Solomon technique is gaining popularity.We therefore consider
it important to investigate the impact of laser power and laser
energy on placental tissue. Laser power is defined as the output
wattage of the laser device that can be set by the operator. The total
amount of laser energy (joule) used during a procedure is calcu-
lated automatically by the laser device and is the result of laser
power and the laser time. This study aims to identify the impact of
the level of laser power and the amount of energy used in laser
treatment on placental tissue and pregnancy outcome.
2. Methods
2.1. Data source
For this study, all cases from the Leiden University Medical
Center included in the Solomon Trial [5] were used, as well as all
cases treated in our national referral center after the Solomon study
was concluded.
All subjects treated between 2008 and 2014 at the Leiden Uni-
versity Center during the Solomon trial were eligible for this study.
Inclusion criteria for laser surgery were: monochorionic pregnancy,
gestational age between 13 and 28 weeks, TTTS Quintero stage 1
with severe clinical symptoms of polyhydramnios, or TTTS Quintero
stage 2. For the analyses we extracted data on laser treatment
specifics (including laser power, laser time and total energy usage),
clinical outcome parameters and postpartum color-dye injected
placenta pictures. Details on the color-dye procedure were previ-
ously reported [9].
2.2. Inclusion and exclusion criteria
All cases with an available placenta picture after selective or
Solomon laser were included. Exclusion criteria were: missing
documentation on both total energy and laser power setting,
missing scale on the picture, single fetal demise and re-
intervention laser therapy after the initial laser procedure. Cases
with single fetal demise were excluded because placental macer-
ation hampers color-dye injection. Cases with a re-intervention
laser procedure were excluded because the visible damage couldFig. 1. Left: selective laser coagulation ( marks the laser spotsnot be directly linked to either one of the laser procedures. Pictures
from cases with a laser-to-delivery interval under seven days were
excluded from grading, because these pictures showed no or little
scarring.
2.3. Scoring placental tissue damage
In the absence of a validated scoring system for placental tissue
damage, we developed one (Table 1) based on validated scar scales
[10,11]. The amount of damage of each grade was measured in
millimeters length and expressed as percentages of the total
lasered line in Solomon cases, or lasered sections in selective cases
of the placenta. In pictures that had a missing scale but showed an
umbilical cord clamp, the clamp was used to gauge the scale.
Measurements were performed using ImageJ 1.47v software
(ImageJ, National Institutes of Health, Bethesda, Maryland, USA).
Placental tissue damage was defined as the summed up value of
grade 2 and 3 tissue damage. These two categories most likely cover
the damage that is considered to be more severe than intended
with laser coagulation. Two observers (SdV and JA) assessed all
pictures independently and blinded from outcome, patient and
procedural parameters. Inter-observer variability was assessed
calculating the intraclass correlation coefficient. In cases with an
inter-observer scoring difference of >5% of the tissue damage score,
the case was discussed by the observers until consensus was ach-
ieved. We used the mean value of the tissue damage scores of both
observers combined for analyses.
2.4. Analysis
The influence of laser power and laser energy on placental tissue
damage was analyzed. Further analyses were conducted to deter-
mine the relation of placental tissue damage, laser power and laser
energy to various outcome parameters. These included gestational
age (GA) at birth, laser-to-delivery interval and preterm prelabor
rupture of membranes (PPROM) before 32 weeks' gestation.
2.5. Statistical analysis
Analyses were conducted using SPSS Statistics (IBM Corp.
Released 2011. IBM SPSS Statistics for Windows, Version 20.0.
Armonk, NY: IBM Corp.). Analysis for risk factors, visual placental
tissue damage, laser power and laser energy, influencing either the
gestational age at birth, laser-to-delivery interval and PPROMunder
32 weeks gestation was conducted using univariate and multivar-
iate regression methods. Normality of all variables was asessed
prior to moddeling. The potential risk factors for each of the three
outcomes were studied in a univariate regression model. The
multivariate regression model included all factors that showed). Right: Solomon laser coagulation ( marks the laser line).
Table 1
Placental damage grading systemwithmedian damage scored per category and technique. Proportion expressed in percentages of total vascular equator. Mann-WhitneyU test.
The numbers in the pictures correspond with the damage grading category.
Category Definition Selective Technique Solomon Technique P-value
Median % (range) Median % (range)
Grade 0 No visible signs of laser coagulation 70,1 (13e94) 3,4 (0e89) <0.001
Grade 1 Membranes intact, white/brownish 15,1 (0e58) 46,2 (0e98) <0.001
Grade 2 Membranes perforated, red 4,6 (0e31) 19,0 (0e87) <0.001
Grade 3 Underlying tissue damaged, irregular surface 7,5 (0e59) 13,0 (0e100) 0.021
Grade 2 þ 3 Grade 2 and 3 combined 15,1 (0e59) 41,8 (0e100) <0.001
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expressed as regression coefficients (B) with 95% confidence in-
tervals (95%CI). Numerical variables with a normal distribution
were expressed in mean (SD) and variables with a skewed distri-
bution were expressed in median (range). Group differences were
compared using the ManneWhitney U test, the independent Stu-
dent's t-test or the one-way ANOVA, as appropriate. A p-value of
<0.05 was considered statistically significant.3. Results
3.1. Selected cases
A total of 159 placenta pictures, documented after selective
(n ¼ 44 (28%)) or Solomon (n ¼ 115 (72%)) laser coagulation, were
available for this study. Included selective laser cases were treated
between March 2008eJune 2012 and included Solomon cases be-
tween January 2008eJanuary 2014. Four cases were excluded
because of single fetal demise with partial placental maceration, and
threebecausea second laserprocedurewasperformed.Nopicturesof
double demise caseswere available. Data on both laser power setting
and total energy was missing in 17 cases, all in the Solomon group.
Another 10 cases were excluded due to missing scale or inadequate
quality of the picture. Finally, three pictures were excluded from
grading because of a laser-to-delivery interval within 7 days. These
cases were lasered at 25þ 3, 22þ 0 and 25þ 5 weeks GA and could
not be scoreddue to insufficient visual placental scarring. In total,122
placenta pictureswere included in this study, 44 (36%) after selective
laser and 78 (64%) after Solomon laser.
3.2. Case characteristics
The mean GA at laser was 20 (±3) weeks and mean GA at birthwas 32 (±5) weeks (Table 2). Seven cases were lasered after 26
weeks' gestation, with a maximum GA at laser of 28þ 4 weeks. The
placenta was localized posterior in 57% of the cases. Most lasers
were performed for TTTS with Quintero stage 3 (49%). One of the
cases involved a dichorionic triplet pregnancy, with a mono-
chorionic component. Two placentas were lasered for the treat-
ment of TAPS. The Nd:YAG laser (Dornier Fibertom 5100) was
replaced by a diode laser (Dornier Medilas D Multibeam) in May
2013 due to regular replacement of equipment. Thirteen of the 78
Solomon cases in this study were lasered using the diode laser,
generally with lower power levels compared to the Nd:YAG laser, in
sub analyses laser type had no effect on the outcome of this study.
All case characteristics and procedural parameters are shown in
Table 2.3.3. Grading
The 122 pictures were scored using the tissue damage grading
system. The mean proportion of damage, expressed as the per-
centage of the total vascular equator for each grade is shown in
Table 1 for both selective and Solomon cases. Placental tissue
damage was found more frequently in the Solomon group (42%)
compared to the selective group (15%) (p < 0.001). Inter observer
variability in defining grade 2 and 3 damage was good with an
intraclass correlation of 0.997 (95%CI 0.995e0.998). In 5 cases we
found an inter-observer grading difference of >5%, these cases were
discussed by both observers blinded from procedural and outcome
parameters until consensus was reached.3.4. Associations with placental damage
Analysis of factors associated with grade 2 and 3 placental tissue
damage is shown in Table 3. Since gestational age at laser was
Table 2
Baseline characteristics.
All cases (n ¼ 122) Selective Technique (n ¼ 44) Solomon Technique (n ¼ 78) P-value
Case Characteristics
Quintero stage
Stage 1 15 (12) 7 (16) 8 (10) 0.762
Stage 2 38 (31) 12 (27) 26 (33)
Stage 3 60 (49) 23 (52) 37 (47)
Stage 4 6 (5) 2 (5) 4 (5)
Placenta localization
Anterior 48 (39) 17 (39) 31 (40) 0.375
Posterior 69 (57) 27 (61) 42 (54)
Lateral 4 (3) 0 (0) 4 (5)
Anterior and posterior 1 (1) 0 (0) 1 (1)
Laser type
YAG 109 (89) 44 (100) 65 (83) 0.004*
Diode 13 (11) NA 13 (17)
GA at laser 142 (±22) 141 (±20) 143 (±23) 0.633
GA at birth 229 (±23) 228 (±26) 229 (±21) 0.775
Pregnancy prolongation 86 (±30) 87 (±29) 86 (±31) 0.900
Procedural Parameters
Fetoscopy time (min) 28 (±11) 23 (±9) 30 (±11) 0.004
Maximum power setting (watt) 53 (±15) 55 (±12) 53 (±16) 0.477
YAG 55 (±14) 55 (±12) 56 (±15) 0.665
Diode 36 (±14) NA 36 (±14) NA
Total laser energy (joule) 5668 (673e32300) 2704 (673e20500) 7171 (797e32300) <0.001*
YAG 5998 (673e32300) 2704 (673e20500) 8070 (2285e32300) <0.001*
Diode 4175 (797e14924) NA 4175 (797e14924) NA
Amount anastomoses 6 (2e23) 6 (2e19) 6 (2e23) 0.841
All categorical values are expressed as N(%). All numerical values are expressed as mean (SD) or median (range). GA laser, GA birth and Pregnancy prolongation are reported in
number of days. Pregnancy prolongation is defined as the number of days of pregnancy prolongation after laser therapy until the delivery.
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p < 0.001), laser energy (Spearman correlation 0.297; p < 0.001)
and the laser-to-delivery interval (Spearman correlation 0.635;
p < 0.001), multivariate analyses were performed. Multivariate
analysis showed that laser energy (p < 0.01) was positively asso-
ciated and that laser power (p ¼ 0.027) was negatively associated
with more placental damage (grade 2 and 3 damage combined).
The amount of grade 2 and 3 placental damage negatively affected
the GA at birth as shown in Table 4 (p ¼ 0.020). Table 4 also shows
that less grade 2 and 3 placental damage (p¼ 0.020) and a lower GA
at laser (p < 0.01) were both associated with a longer laser-to-
delivery interval in multivariate analysis. This finding was the
same for PPROM <32 weeks' gestation. More grade 2 and 3 damage
(p¼ 0.031) and a lower GA at laser (p¼ 0.029) were associatedwith
a higher rate of early PPROM as shown in Table 4.4. Discussion
4.1. Main findings
In this study, we evaluated the impact of gestational age of laser,
laser power, laser total energy and post-partum visual placental
damage after laser treatment for TTTS on pregnancy outcome. Vi-
sual tissue damage appeared to be a significant risk factor for a
higher incidence of PPROMunder 32weeks' gestation and a shorter
laser-to-delivery interval and a lower GA at birth. Cases with more
extensively damaged placentas more often developed PPROM andTable 3
Analysis of factors contributing to grade 2 and 3 damage.
Variable Univariate analysis B (95% CI) SE P
Laser power 0,256 (0,596 to -0,070) 0,166 002
Laser energy 0,001 (0,000 - 0,002) 0,000 <0
GA at laser 0,106 (0,335e0,123) 0,116 036
Values are regression coefficient B (95%CI, standard error (SE) and P. Values representedhad a lower GA at birth compared to cases with less placental tissue
damage. Anterior placenta localization did not lead to use of more
laser energy or more placental tissue damage. More laser energy
used during the procedure was associated with more extensive
placental damage, whereas a higher power setting was found to
lead to less damage. Furthermore, we found a significant correla-
tion between GA at laser with laser power and laser energy used.4.2. Interpretation
The correlation of GA at laser with laser power, and total energy
is most likely explained by the fact that the superficial placental
vessels increase in diameter over time, and concurrently the fetal
blood volume increases during pregnancy [12]. Larger vascular
diameter requires more energy to achieve successful coagulation of
the vessel and a higher power setting delivers this energy more
rapidly. The significant association between laser power and laser-
to-delivery interval in the univariate linear regression model is
explained by the strong correlation of both variables with GA at
laser. Higher laser power settings are used in cases with more
advanced GA and these cases are associatedwith shorter pregnancy
prolongation than cases with laser therapy at earlier GA.
With the results of this study, we speculate that higher total
energy use in laser treatment for TTTS leads to significantly more
placental tissue damage. Higher laser power showed the opposite
effect. We hypothesize that, with a higher power setting, energy
transfer is more effective and takes shorter time and less energyMultivariate analysis B (95% CI) SE P
2 0,442 (0,833 to -0,050) 0,198 0027
,01 0,002 (0,001e0,003) 0,000 <0,01
1 0,072 (0,327e0,183) 0,129 0577
in bold script represent a significance level of p < 0.05
Table 4
Analysis of factors associated with different outcomes.
Variable Univariate analysis B (95% CI) SE P Multivariate analysis B (95% CI) SE P
Factors associated with gestational age at birth
Laser power 0,045 (0,233e0,323) 0,140 0750 0,021 (0,362e0,319) 0,172 0901
Laser energy 0,000 (0,001e0,001) 0,000 0821 0,000 (0,001e0,001) 0,000 0944
Grade 2 and 3 damage 0,163 (0,296 - -0,029) 0,067 0017 0,167 (0,307 - -0,026) 0,071 0020
GA at laser 0,093 (0,098e0,283) 0,096 0338 0,063 (0,158e0,284) 0,111 0563
Factors associated with the laser-to-delivery interval
Laser power 0,646 (0,997 - -0,296) 0,177 <0,01 0,036 (0,388e0,315) 0,177 0838
Laser energy 0,001 (0,002e0,000) 0,000 0244 0,00 (0,001e0,001) 0,000 0871
Grade 2 and 3 damage 0,137 (0,314 - -0,041) 0,090 0130 0,168 (0,306 - -0,026) 0,071 0020
GA at laser 0,907 (1098 - -0,717) 0,096 <0,01 0,937 (1161 - -0,713) 0,113 <0,01
Factors contributing to PPROM before 32 weeks' gestation
Laser power 0,010 (0,016e0.036) 0,010 0450 0,032 (0,003e0,067) 0,018 0073
Laser energy 0,000 (0,000 - 0,000) 0,000 0457 0,000 (0,000 - 0,000) 0,000 0711
Grade 2 and 3 damage 0,015 (0,001e0,028) 0,007 0030 0,016 (0,001e0,030) 0,007 0031
GA at laser 0,016 (0,036e0,003) 0,010 0049 0,026 (0,05 - -0,003) 0,012 0029
Values are regression coefficient B (95%CI, standard error (SE) and P. Values represented in bold script represent a significance level of p < 0.05
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than in a lowpower setting and thus leads to less collateral damage.
This study is the first to systematically evaluate and score
placental damage in relation to laser power, time and total energy.
Previous studies showed a relation between laser power setting
and tissue damage in tissues other than placenta. Kirschbaum et al.
[13] showed a significant positive correlation between laser power
output and the mean cutting depth in paracardiac lung lobes of
pigs. Likewise, an ex-vivo experiment on kidney models by Khoder
et al. [14] showed a nearly linear increase of ablation depth with
increasing laser power output. These studies were performed in an
experimental setting and used interstitial laser techniques. In
contrast to the laser therapy for TTTS, interstitial laser treatment is
used for direct tissue destruction. Hence, tissue damage could be
analyzed more precise because the effect is directly visible after
treatment. With the interstitial laser technique, the transfer of
energy to the tissue is direct, whereas in laser therapy for TTTS the
distance between the tip of the laser fiber to the placenta highly
impacts effective energy transfer [14].
Firing distance and angle are thought to be important factors
influencing effective energy transfer to the tissue. These factors are
difficult to control and hard to measure in vivo. Khoder et al. [14]
showed a significant reduction in ablation depth with increasing
tissue distance in experimental setting. A higher power setting is
necessary in order to achieve tissue ablation because laser energy is
lost in the distance between the laser fiber and tissue. The true
influence of firing angle is unclear. Theoretically, because the ves-
sels are localized on the placental surface, a wide range of angles
should lead to comparable energy transmission onto the vessel.
Future studies should provide more knowledge about the optimal
distance and angle for laser therapies.
The optimal laser power setting for laser coagulation of
placental vessels is unknown. A wide range of laser power setting
and technique is used worldwide [8]. It is also unclear whether
coagulating with a high laser power setting for a short time span
would lead to different results than coagulating longer with a lower
laser power. It is plausible that various settings lead to different
tissue effects. Branisteau et al. addressed the effect of laser coagu-
lation on placental tissue using an in-vivo ovine placenta model.
Results showed that the tissue effects, in time, spread beyond the
surface and induces complete functional elimination of the
involved cotyledon [6]. The results of this study might imply that
the operator should strive towards superficial coagulation of the
placental tissue in order to obtain complete cotyledon elimination
while avoiding the risk of complications as PPROMor early delivery.In order to decrease the amount of energy used during a Solo-
mon procedure for treating TTTS one could lower the laser power
setting during coagulation between true anastomoses. More
research on human placentas is necessary in order to confirm this,
the results of this study, and to determine the optimal laser power
setting.4.3. Limitations
An important limitation in this study is the case selection of
treated pregnancies with two live born children. This prevents us
from drawing conclusions about the strong outcome measure of
survival. Furthermore, documentation on laser power included
only the maximum used setting. In most of the cases this is the
predominant setting used during a procedure, however, in some
cases the results might be influenced because themaximum setting
was used for only a short time span.
Another limitation of this type of study is the retrospective
nature, based on placenta pictures and not live tissue preventing us
to use other anticipated important factors as number, type and
caliber of anastomoses and placental weight. Finally, a wide range
of pregnancy prolongation after laser was present in our sample.
Scar tissue develops in time and therefore it is possible that cases
with a short prolongation are graded differently than ones with a
longer prolongation, even though perhaps the same scarring would
have developed within more time.5. Conclusion
We found a significant association between laser power and
total energy used during laser treatment for TTTS and postpartum
placental tissue damage. More energy leads to more damage
whereas a higher power setting leads to less damage. In this study,
greater tissue damage was associated with a lower GA at birth, a
higher PPROM rate under 32weeks' gestation and a shorter laser-to
delivery interval. These early results of our research into detailed
technical aspects of fetoscopic laser surgery should be interpreted
with caution, we do not recommend changes in practice at this
time. We do believe more in-depth analysis of all details of feto-
scopic surgery may ultimately lead to improvements in outcome.Disclosure
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